CSPC PHARMACEUTICAL (CVG.SG)
CSPC PHARMACEUTICAL (CVG.SG) operates in Diversified Metals & Mining.
CSPC PHARMACEUTICAL (CVG.SG) (CVG) - Net Assets
Latest net assets as of December 2023: €35.02 Billion EUR
Based on the latest financial reports, CSPC PHARMACEUTICAL (CVG.SG) (CVG) has net assets worth €35.02 Billion EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€46.28 Billion) and total liabilities (€11.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €35.02 Billion |
| % of Total Assets | 75.66% |
| Annual Growth Rate | 21.19% |
| 5-Year Change | 79.41% |
| 10-Year Change | N/A |
| Growth Volatility | 9.05 |
CSPC PHARMACEUTICAL (CVG.SG) - Net Assets Trend (2016–2023)
This chart illustrates how CSPC PHARMACEUTICAL (CVG.SG)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CSPC PHARMACEUTICAL (CVG.SG) (2016–2023)
The table below shows the annual net assets of CSPC PHARMACEUTICAL (CVG.SG) from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €35.02 Billion | +10.67% |
| 2022-12-31 | €31.64 Billion | +17.94% |
| 2021-12-31 | €26.83 Billion | +16.13% |
| 2020-12-31 | €23.10 Billion | +18.36% |
| 2019-12-31 | €19.52 Billion | +25.93% |
| 2018-12-31 | €15.50 Billion | +20.38% |
| 2017-12-31 | €12.87 Billion | +41.09% |
| 2016-12-31 | €9.13 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to CSPC PHARMACEUTICAL (CVG.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 355.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €24.03 Billion | 72.39% |
| Other Components | €9.17 Billion | 27.61% |
| Total Equity | €33.20 Billion | 100.00% |
CSPC PHARMACEUTICAL (CVG.SG) Competitors by Market Cap
The table below lists competitors of CSPC PHARMACEUTICAL (CVG.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UPD Holding Corp
PINK:UPDC
|
$9.59K |
|
430460
KQ:430460
|
$9.59K |
|
46IE
LSE:46IE
|
$9.60K |
|
CardioGenics Holdings Inc
PINK:CGNH
|
$9.61K |
|
Ormester Vagyonvedelmi Nyrt.
BUD:ORM
|
$9.58K |
|
Miciso Real Estate SOCIMI S.A.
MC:YMCS
|
$9.56K |
|
266170
KO:266170
|
$9.55K |
|
SPORTING
MU:SCG
|
$9.55K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CSPC PHARMACEUTICAL (CVG.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 30,197,534,000 to 33,203,208,000, a change of 3,005,674,000 (10.0%).
- Net income of 5,873,325,000 contributed positively to equity growth.
- Dividend payments of 2,726,253,000 reduced retained earnings.
- Share repurchases of 200,358,000 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.87 Billion | +17.69% |
| Dividends Paid | €2.73 Billion | -8.21% |
| Share Repurchases | €200.36 Million | -0.6% |
| Other Changes | €58.96 Million | +0.18% |
| Total Change | €- | 9.95% |
Book Value vs Market Value Analysis
This analysis compares CSPC PHARMACEUTICAL (CVG.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.88x to 0.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €1.07 | €0.94 | x |
| 2018-12-31 | €1.25 | €0.94 | x |
| 2019-12-31 | €1.54 | €0.94 | x |
| 2020-12-31 | €1.87 | €0.94 | x |
| 2021-12-31 | €2.17 | €0.94 | x |
| 2022-12-31 | €2.53 | €0.94 | x |
| 2023-12-31 | €2.79 | €0.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CSPC PHARMACEUTICAL (CVG.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.69%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.68%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.39x
- Recent ROE (17.69%) is below the historical average (20.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 20.78% | 16.98% | 0.84x | 1.46x | €976.07 Million |
| 2017 | 18.08% | 17.92% | 0.72x | 1.41x | €1.03 Billion |
| 2018 | 21.37% | 17.38% | 0.80x | 1.54x | €1.71 Billion |
| 2019 | 20.12% | 16.80% | 0.84x | 1.43x | €1.87 Billion |
| 2020 | 23.10% | 20.69% | 0.83x | 1.35x | €2.93 Billion |
| 2021 | 21.57% | 20.11% | 0.80x | 1.34x | €3.01 Billion |
| 2022 | 20.17% | 19.69% | 0.74x | 1.38x | €3.07 Billion |
| 2023 | 17.69% | 18.68% | 0.68x | 1.39x | €2.55 Billion |
Industry Comparison
This section compares CSPC PHARMACEUTICAL (CVG.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $107,279,526,363
- Average return on equity (ROE) among peers: 7.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CSPC PHARMACEUTICAL (CVG.SG) (CVG) | €35.02 Billion | 20.78% | 0.32x | $9.58K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $973.51K |
| Tokyu Corporation (01T) | $747.05 Billion | 9.38% | 2.03x | $93.98K |
| GUANGZHOU AUTO -H- (02G) | $77.92 Billion | 13.99% | 0.70x | $4.23K |
| MOSAIC (02M) | $9.37 Billion | -11.39% | 1.06x | $267.55K |
| MOSAIC (02M.SG) (02M) | $10.72 Billion | 9.59% | 0.71x | $264.31K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $22.74 Million | -14.04% | 3.68x | $1.51 Million |
| KRAKATAU STEEL -B- (07K) | $587.19 Million | 7.57% | 5.43x | $166.88 |
| CN MODERN DAIRY (07M.SG) (07M) | $8.04 Billion | 9.58% | 0.94x | $1.66K |
| TOURMALINE OIL (08T) | $13.69 Billion | 32.78% | 0.38x | $376.57K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $343.89 |